Willow Financial Statements From 2010 to 2026
| CANSF Stock | USD 0.12 0.01 9.09% |
Check Willow Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Willow Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Willow financial statements analysis is a perfect complement when working with Willow Biosciences Valuation or Volatility modules.
Willow |
Willow Biosciences OTC Stock Current Valuation Analysis
Willow Biosciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Willow Biosciences Current Valuation | (3.21 M) |
Most of Willow Biosciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Willow Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Willow Biosciences has a Current Valuation of (3.21 Million). This is 100.02% lower than that of the Metals & Mining sector and significantly lower than that of the Materials industry. The current valuation for all United States stocks is 100.02% higher than that of the company.
Willow Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Willow Biosciences's current stock value. Our valuation model uses many indicators to compare Willow Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Willow Biosciences competition to find correlations between indicators driving Willow Biosciences's intrinsic value. More Info.Willow Biosciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Willow Biosciences' earnings, one of the primary drivers of an investment's value.About Willow Biosciences Financial Statements
Willow Biosciences stakeholders use historical fundamental indicators, such as Willow Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Willow Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Willow Biosciences' assets and liabilities are reflected in the revenues and expenses on Willow Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Willow Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada. Willow Biosciences is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Willow OTC Stock
Willow Biosciences financial ratios help investors to determine whether Willow OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.